Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hospitals
Fierce Healthcare
Trump administration restarts its efforts to pilot 340B rebates
Friday’s RFI sets a March 19 deadline for stakeholders to weigh in on what HRSA should consider for its second attempt at a 340B rebate test run.
Dave Muoio
Feb 13, 2026 1:00pm
Fierce Healthcare
CMMI proposes new models to lower drug prices in Parts B, D
Dec 22, 2025 12:00pm
Fierce Healthcare
Medical groups decry CDC's major child vaccine change
Dec 17, 2025 2:00pm
Fierce Healthcare
MAHA Commission unveils broad plan to improve children's health
Sep 9, 2025 5:30pm
Fierce Healthcare
PhRMA launches ad campaign against '340B medicine mark-ups'
Sep 3, 2025 1:30pm
Fierce Healthcare
Hospitals skeptical of 340B rebate pilot's tight comment period
Aug 11, 2025 3:30pm